Cargando…
Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors
Due to the multifaceted pharmacological activities of chalcones, these scaffolds have been considered one of the most privileged frameworks in the drug discovery process. Structurally, chalcones are α, β-unsaturated carbonyl functionalities with two aryl or heteroaryl units. Amongst the numerous pha...
Autores principales: | George, Ginson, Koyiparambath, Vishal Payyalot, Sukumaran, Sunitha, Nair, Aathira Sujathan, Pappachan, Leena K., Al-Sehemi, Abdullah G., Kim, Hoon, Mathew, Bijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953944/ https://www.ncbi.nlm.nih.gov/pubmed/35328542 http://dx.doi.org/10.3390/ijms23063121 |
Ejemplares similares
-
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021) -
Navigating into the Chemical Space of Monoamine Oxidase
Inhibitors by Artificial Intelligence and Cheminformatics Approach
por: Kumar, Sunil, et al.
Publicado: (2021) -
Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
por: Nair, Aathira Sujathan, et al.
Publicado: (2021) -
Exploration of the Detailed Structure–Activity
Relationships of Isatin and Their Isomers As Monoamine Oxidase Inhibitors
por: Kumar, Sunil, et al.
Publicado: (2022) -
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer’s Disease
por: Kumar, Astik, et al.
Publicado: (2023)